4//SEC Filing
CHIMERIX INC 4
Accession 0001012975-14-000555
CIK 0001117480operating
Filed
Sep 10, 8:00 PM ET
Accepted
Sep 11, 5:34 PM ET
Size
22.5 KB
Accession
0001012975-14-000555
Insider Transaction Report
Form 4
CHIMERIX INCCMRX
NIEDEL JAMES
Director10% Owner
Transactions
- Sale
Common Stock
2014-09-09$29.67/sh−58,531$1,736,615→ 1,267,542 total(indirect: See Footnote) - Exercise of In-Money
Common Stock
2014-09-09$7.26/sh+200,879$1,458,382→ 1,468,421 total(indirect: See Footnote) - Sale
Common Stock
2014-09-09$28.54/sh−51,100$1,458,394→ 1,417,321 total(indirect: See Footnote) - Sale
Common Stock
2014-09-11$29.58/sh−328,680$9,722,354→ 1,046,082 total(indirect: See Footnote) - Exercise of In-Money
Warrant
2014-09-09−200,879→ 401,758 total(indirect: See Footnote)Exercise: $7.26Exp: 2018-02-07→ Common Stock (200,879 underlying) - Exercise of In-Money
Warrant
2014-09-10−401,758→ 0 total(indirect: See Footnote)Exercise: $7.26Exp: 2018-02-07→ Common Stock (401,758 underlying) - Sale
Common Stock
2014-09-09$28.72/sh−217,321$6,241,459→ 1,326,073 total(indirect: See Footnote) - Sale
Common Stock
2014-09-10$29.54/sh−347,188$10,255,934→ 1,070,133 total(indirect: See Footnote) - Exercise of In-Money
Common Stock
2014-09-10$7.26/sh+401,758$2,916,763→ 1,471,891 total(indirect: See Footnote) - Sale
Common Stock
2014-09-10$30.03/sh−97,129$2,916,784→ 1,374,762 total(indirect: See Footnote)
Footnotes (8)
- [F1]The price reported in Column 4 is a weighted average price (net of commissions of $0.04 per share). These shares were sold in multiple transactions at prices ranging from $28.50 to $29.49, inclusive. The Reporting Person undertakes to provide to CMRX, any security holder of CMRX, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1, 3, 5 and 7.
- [F2]The securities are directly held by New Leaf Ventures II, L.P. ("NLV II") and indirectly held by New Leaf Venture Associates II, L.P. ("NLV Associates"), the sole general partner of NLV II, and New Leaf Venture Management II, L.L.C. ("NLV Management"), the sole general partner of NLV Associates. As an individual manager of NLV Management, along with five other individual managers, the Reporting Person may be deemed to beneficially own the shares to which this Form 4 relate. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
- [F3]The price reported in Column 4 is a weighted average price (net of commissions of $0.04 per share). These shares were sold in multiple transactions at prices ranging from $29.50 to $29.73, inclusive.
- [F4]On September 9, 2014, NLV II exercised warrants to purchase 200,879 shares of CMRX common stock for $7.26 a share. NLV II paid the exercise price on a cashless basis, resulting in CMRX's withholding of 51,100 of the warrant shares to pay the exercise price and issuing to NLV II the remaining 147,779 shares.
- [F5]The price reported in Column 4 is a weighted average price (net of commissions of $0.04 per share). These shares were sold in multiple transactions at prices ranging from $29.16 to $30.03, inclusive.
- [F6]On September 10, 2014, NLV II exercised warrants to purchase 401,758 shares of CMRX common stock for $7.26 a share. NLV II paid the exercise price on a cashless basis, resulting in CMRX's withholding of 97,129 of the warrant shares to pay the exercise price and issuing to NLV II the remaining 304,629 shares.
- [F7]The price reported in Column 4 is a weighted average price (net of commissions of $0.04 per share). These shares were sold in multiple transactions at prices ranging from $29.50 to $30.43, inclusive.
- [F8]The Warrants are immediately exercisable.
Documents
Issuer
CHIMERIX INC
CIK 0001117480
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001117480
Filing Metadata
- Form type
- 4
- Filed
- Sep 10, 8:00 PM ET
- Accepted
- Sep 11, 5:34 PM ET
- Size
- 22.5 KB